Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ANK2 | Q01484 | Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin) | Disease related genesHuman disease related genesPlasma proteins | Fusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.50 | ||||
| ANKL2 | Q86XL3 | Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4) | Disease related genesEssential proteinsHuman disease related genes | 1 | Receptor-signaling mediation | 1 | 0.50 | |||
| ANO1 | Q5XXA6 | Anoctamin-1 (Discovered on gastrointestinal stromal tumors protein 1) (Oral cancer overexpressed protein 2) (Transmembrane protein 16A) (Tumor-amplified and overexpressed sequence 2) | Disease related genesFDA approved drug targetsPlasma proteins | 10 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| APC | P25054 | Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5) | Cancer-related genesDisease related genesHuman disease related genes | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||||
| AQP4 | P55087 | Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4) | Human disease related genesMetabolic proteinsPredicted membrane proteins | 6 | Fusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| AT1A1 | P05023 | Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1) | Cancer-related genesDisease related genesEnzymes | 10 | Cardiac arrhythmiaChronic obstructive pulmonary diseaseCorneal disease | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| AT2A2 | P16615 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) | Disease related genesEnzymesEssential proteins | 10 | AsthmaHeart failureHypertension | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| AT2B1 | P20020 | Plasma membrane calcium-transporting ATPase 1 (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 1) (PMCA1) (Plasma membrane calcium pump isoform 1) | Disease related genesEnzymesFDA approved drug targets | 10 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| AT2B3 | Q16720 | Plasma membrane calcium-transporting ATPase 3 (PMCA3) (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 3) (Plasma membrane calcium pump isoform 3) | Cancer-related genesDisease related genesEnzymes | 10 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| AT2C2 | O75185 | Calcium-transporting ATPase type 2C member 2 (ATPase 2C2) (EC 7.2.2.10) (Ca(2+)/Mn(2+)-ATPase 2C2) (Secretory pathway Ca(2+)-transporting ATPase type 2) (SPCA2) | EnzymesFDA approved drug targetsMetabolic proteins | 10 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | |||
| AT8A2 | Q9NTI2 | Phospholipid-transporting ATPase IB (EC 7.6.2.1) (ATPase class I type 8A member 2) (ML-1) (P4-ATPase flippase complex alpha subunit ATP8A2) | Disease related genesEnzymesHuman disease related genes | 10 | Fusion and delivery mediation | 1 | 0.50 | |||
| AT8B1 | O43520 | Phospholipid-transporting ATPase IC (EC 7.6.2.1) (ATPase class I type 8B member 1) (Familial intrahepatic cholestasis type 1) (P4-ATPase flippase complex alpha subunit ATP8B1) | Disease related genesEnzymesHuman disease related genes | 10 | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| BFSP1 | Q12934 | Filensin (Beaded filament structural protein 1) (Lens fiber cell beaded-filament structural protein CP 115) (CP115) (Lens intermediate filament-like heavy) (LIFL-H) [Cleaved into: Filensin C-terminal fragment; Filensin N-terminal fragment] | Disease related genesHuman disease related genesPredicted intracellular proteins | Fusion and delivery mediation | 1 | 0.50 | ||||
| BFSP2 | Q13515 | Phakinin (49 kDa cytoskeletal protein) (Beaded filament structural protein 2) (Lens fiber cell beaded filament protein CP 47) (CP47) (Lens fiber cell beaded filament protein CP 49) (CP49) (Lens intermediate filament-like light) (LIFL-L) | Disease related genesHuman disease related genesPredicted intracellular proteins | Fusion and delivery mediation | 1 | 0.50 | ||||
| BMPR2 | Q13873 | Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II) | Disease related genesEnzymesFDA approved drug targets | 1 | Joint derangementProstate cancerUrinary system disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| C1QBP | Q07021 | Complement component 1 Q subcomponent-binding protein, mitochondrial (ASF/SF2-associated protein p32) (Glycoprotein gC1qBP) (C1qBP) (Hyaluronan-binding protein 1) (Mitochondrial matrix protein p32) (gC1q-R protein) (p33) (SF2AP32) | Cancer-related genesDisease related genesHuman disease related genes | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 1 | 0.50 | ||||
| CAC1C | Q13936 | Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2) | Disease related genesFDA approved drug targetsHuman disease related genes | 24 | Alzheimer diseaseAngina pectorisGenetic cardiac arrhythmia | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||
| CADH1 | P12830 | Cadherin-1 (CAM 120/80) (Epithelial cadherin) (E-cadherin) (Uvomorulin) (CD antigen CD324) [Cleaved into: E-Cad/CTF1; E-Cad/CTF2; E-Cad/CTF3] | Cancer-related genesCD markersDisease related genes | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| CADH2 | P19022 | Cadherin-2 (CDw325) (Neural cadherin) (N-cadherin) (CD antigen CD325) | CD markersDisease related genesHuman disease related genes | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| CADH3 | P22223 | Cadherin-3 (Placental cadherin) (P-cadherin) | Disease related genesHuman disease related genesPredicted intracellular proteins | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| CANB1 | P63098 | Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1) | FDA approved drug targetsPredicted intracellular proteins | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||||
| CAV3 | P56539 | Caveolin-3 (M-caveolin) | Disease related genesHuman disease related genesPotential drug targets | Adhesion and uptake mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||||
| CAVN1 | Q6NZI2 | Caveolae-associated protein 1 (Cavin-1) (Polymerase I and transcript release factor) | Disease related genesHuman disease related genesPlasma proteins | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| CD2 | P06729 | T-cell surface antigen CD2 (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD antigen CD2) | CD markersFDA approved drug targetsPredicted intracellular proteins | 1 | LymphomaPsoriasis | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| CD20 | P11836 | B-lymphocyte antigen CD20 (B-lymphocyte surface antigen B1) (Bp35) (Leukocyte surface antigen Leu-16) (Membrane-spanning 4-domains subfamily A member 1) (CD antigen CD20) | CD markersDisease related genesFDA approved drug targets | 4 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 |